J. Russel Denton - 03 Mar 2025 Form 4 Insider Report for Caris Life Sciences, Inc.

Role
Senior Vice President, General Counsel, and Secretary
Signature
/s/ J. Russel Denton
Issuer symbol
CAI on Nasdaq
Transactions as of
03 Mar 2025
Net transactions value
-$4,273,578
Form type
4
Filing time
23 Jun 2025, 18:34:51 UTC
Next filing
17 Jun 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Denton John Russel Senior Vice President, General Counsel, and Secretary C/O CARIS LIFE SCIENCES, INC., 750 W. JOHN CARPENTER FREEWAY, SUITE 800, IRVING /s/ J. Russel Denton 23 Jun 2025 0002071923

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CAI Common Stock Disposed to Issuer $4,431,078 -238,230 -93% $18.60 16,770 03 Mar 2025 Direct F1, F2
transaction CAI Common Stock Award $0 +99,321 +592% $0.000000 116,091 18 Jun 2025 Direct F3
transaction CAI Common Stock Purchase $157,500 +7,500 +6.5% $21.00 123,591 20 Jun 2025 Direct
holding CAI Common Stock 5,000 03 Mar 2025 By Trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CAI Stock Option Award $0 +255,000 $0.000000 255,000 03 Mar 2025 Common Stock 255,000 $18.60 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares of Common Stock surrendered to the Issuer as repayment for an outstanding promissory note.
F2 These securities were previously reported on the Reporting Person's Form 3. All the securities reported in this Form 4 reflect a one-for-four reverse stock split effected as of June 1, 2025.
F3 Represents an award of restricted stock units which vest in accordance with the applicable grant agreement.
F4 The stock option vested 60% at grant and will vest 20% on September 1, 2025 and 20% on September 1, 2026. These securities were previously reported on the Reporting Person's Form 3.

Remarks:

Senior Vice President, General Counsel, and Secretary